Pfizer
17:15 :
Pfizer Recalls More Than 650,000 Bottles Of Advil Liqui-Gels -
--No safety concerns were associated with the recall By Peter Loftus Of DOW JONES NEWSWIRES Pfizer Inc. (PFE) recently recalled more than 650,000 bottles of Advil pain-relief medicine due to the potential for a strong odor in the product. ...
19:44 :
FDA Panel Recommends Approval Of Pfizer's Tofacitinib -
By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- A federal advisory panel backed the approval of a proposed Pfizer Inc. (PFE) drug for rheumatoid arthritis, but recommended limits on the types of patients who should ...
20:57 :
FDA Approves Protalix, Pfizer Drug To Treat Gaucher Disease -
By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- The Food and Drug Administration Tuesday approved a new treatment developed by Protalix Bio Therapeutics Inc. (PLX, PLX.TV) for children and adults with a type of Gaucher disease, ...
16:41 :
Nestlé buys Pfizer Nutrition: Feeding little emperors -
The great maw of
China BABY food looks like glop, but it is an attractive business. Global sales are $30 billion and growing by 10% annually, mostly thanks to developing countries. That is why Nestlé, a Swiss food giant, is paying so much ...
06:57 :
Sobi : Interim Report, January - March 2012 -
Geoffrey McDonough, CEO: "The first quarter marks a solid beginning for 2012 with consistent growth across our product business lines. We finalized two significant transactions with Pfizer and made an important revision of the agreement ...
01:56 :
Nestle may sell part of Pfizer assets - report -
NEW YORK (Reuters) - Swiss food group Nestle SA may sell about 10 to 15 percent of the $11.9 billion (7.3 billion pounds) baby food business it is buying from Pfizer Inc to address antitrust concerns, Bloomberg News reported on Monday.
05:57 :
Nestle to buy Pfizer Nutrition for $11.9 billion -
ZURICH (Reuters) - Swiss food group Nestle said on Monday it would buy U.S. drugmaker Pfizer's infant nutrition business for $11.85 billion (7.35 billion pounds), beating out French rival
Danone as both sought to gain preeminence in the ...
00:13 :
Nestlé may have deal to buy Pfizer baby milk -
Nestlé, the world's biggest food group, is closing in on a deal to buy Pfizer's baby food business for up to $10bn (£6bn) to boost its business in
China and extend its lead in the world of formula milk.
23:48 :
Amgen To Assume Certain Pfizer Sales Duties For Enbrel In US -
By Peter Loftus Of DOW JONES NEWSWIRES Pfizer Inc. (PFE) will soon shift certain U.S. promotional responsibilities for the blockbuster anti-inflammatory drug Enbrel to its marketing partner, Amgen Inc. (AMGN), as the drug makers prepare ...
15:36 :
EARNINGS PREVIEW: US Drug Makers' Patent Cliff To Dominate 1Q -
By Tess Stynes Of DOW JONES NEWSWIRES TAKING THE PULSE: The drug industry's patent cliff likely will remain in focus during the first quarter as Pfizer Inc. (PFE) reports its first full period without market exclusivity for former blockbuster ...
08:42 :
Pfizer scraps deal with Biocon -
US drugmaker Pfizer has scrapped a deal to sell insulin products made by Biocon Ltd, in what is set to be a major blow for India's largest listed biotech firm.
22:33 :
UPDATE 1-Durect's partner Pfizer to end pain drug deal -
March 1 (Reuters) - Specialty pharmaceutical company Durect Corp said its partner Pfizer Inc will terminate their agreement for the development and commercialization of a patch to treat chronic low-back pain.
21:16 :
Pfizer weighs plans to raise $3bn -
The pharmaceuticals group is looking at a part-flotation of its animal health division and has been talking to bankers about arranging an initial public offering
15:09 :
Pfizer beats estimates -
Pfizer, the world's largest drug maker, reported earnings that beat analysts' estimates as the company's non-pharmaceutical units and cost cutting overcame losses from generic competition to its best-seller Lipitor.
17:00 :
Drugmakers: Cliffhanger -
FOR some years the big drugmakers have been dreading an approaching “patent cliff”—a slump in sales as the patents on their most popular pills expire or are struck down by legal challenges, with few new potential blockbusters to take their place. This ...
01:16 :
Pfizer hit with $60m bribery bill -
Pfizer, the US pharmaceuticals giant, is set to pay more than $60m (£38m) to settle charges that gifts and payments it paid to doctors in Europe amount to bribes under the US Foreign Corrupt Practices Act (FCPA).
13:43 :
Bristol, Pfizer clot drug fails to help ill patients -
ORLANDO, Fla.,Nov 13 (Reuters) - Bristol-Myers Squibb and Pfizer Inc's apixaban failed to significantly help seriously ill patients cut their risk of dangerous blood clots, according to clinical data released on Sunday.
21:19 :
UPDATE 1-Pfizer in research collaboration with Medco -
Oct 26, Reuters - Pfizer Inc , the world's largest drugmaker, and pharmacy benefit manager Medco Health Solutions Inc said on Wednesday they had set up a research collaboration aimed at better identifying the patients most likely to be helped ...
21:07 :
China's Mengniu eye Pfizer nutrition unit-report -
NEW YORK, Oct 23 (Reuters) - Chinese milk producer Mengniu Dairy is considering a bid for Pfizer's nutrition business as potential buyers prepare for the start of the sales process next month, the Financial Times reported on Sunday.
actualidad Pfizer -